9245 — Livero Income Statement
0.000.00%
- ¥10bn
- ¥8bn
- ¥3bn
- 78
- 23
- 96
- 77
Annual income statement for Livero, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,900 | 2,137 | 2,377 | 2,555 | 2,901 |
Cost of Revenue | |||||
Gross Profit | 1,556 | 1,801 | 2,050 | 2,225 | 2,460 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,680 | 1,822 | 2,017 | 2,477 | 2,762 |
Operating Profit | 220 | 315 | 360 | 77.9 | 139 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 226 | 318 | 346 | 78 | 140 |
Provision for Income Taxes | |||||
Net Income After Taxes | 143 | 225 | 239 | 50.8 | 104 |
Net Income Before Extraordinary Items | |||||
Net Income | 143 | 225 | 239 | 50.8 | 104 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 143 | 225 | 239 | 50.8 | 104 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 26.8 | 42.8 | 45.1 | 8.74 | 23.7 |
Dividends per Share |